A randomized clinical trial of once-weekly exenatide for alcohol use disorder published in JAMA Psychiatry (2022) did not meet its primary endpoint of reducing heavy drinking days in the overall study population
10.1089/ars.2006.8.1865
Considering all the drugs you manufactured are not approved by the agency and your systems for manufacturing sterile drugs are wholly lacking, you should not restart drug manufacturing at this facility, the FDA said
1 Cardiology, University Hospital Aachen, Aachen, Germany, 2 Institute for Epidemiology and Medical Biometry, ZIBMT, Ulm University, Ulm, Germany, 34 USA, 5 Institute for Epidemiology and, Ulm, Germany
Consistent Support: You have access to a dedicated team to answer questions about side effects or plateaus